NCT02142153 - F901318 Single Ascending Dose Study in Healthy Male Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Invasive Aspergillosis

Interventions

DRUG

F901318

"Comparison of adverse events, clinically significant safety laboratory abnormalities and ECG abnormalities.~Pharmacokinetic profile"

DRUG

Placebo

Comparison of adverse events and clinically sign significant safety lab and ECG abnormalities

Trial Locations (1)

Simbec Research, Merthyr Tydfil